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ABSTRACT
Human metapneumovirus (hMPV) genotypes A
and B show epidemiological and probably clinical
differences. This report describes a fast and
simple PCR–restriction fragment length polymor-
phism (PCR-RFLP) assay, involving digestion of
the fusion protein gene with Tsp509I, that allows
lineages A1, A2, B1 and B2 to be distinguished.
The assay should help in elucidating the epide-
miology of hMPV, and possibly in predicting the
severity of clinical infection.
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Human metapneumovirus (hMPV) was first dis-
covered in The Netherlands in 2001 [1]. This virus
causes respiratory tract infection worldwide and
affects individuals of all ages. The severity of
episodes varies frommildupper respiratory symp-
toms to severe infection. Diagnosis of hMPV is
usually performedusing nucleic acid amplification
techniques, as virus isolation is time-consuming
and difficult and there are no standardised sero-
logical tests. The technique used most commonly
involves RT-PCR with primers targeting various
hMPV genes, e.g., the fusion, polymerase, phos-
phoprotein or nucleoprotein genes. Genetic analy-
sis of the fusion (F) gene and the attachment (G)
gene have been used to classify hMPV into two
major genotypes, A and B, each of which is
subdivided into two lineages, A1, A2, B1 and B2
[2]. The samegenotyping groupshave also resulted
from analysis of the nucleoprotein, phosphopro-
tein and small hydrophobic protein genes [3,4].
Phylogenetic studies to distinguish among the
different genotypes are performed by sequencing
a specific gene. Although sequencing is the refer-
ence technique, this approach is expensive, time-
consuming and not available in all laboratories.
The present study describes a fast, simple and
accessible method to identify hMPV genotypes.
The method involves performing a PCR to amplify
the fusion gene, using the primers and conditions
described by Kaida et al. [5], followed by an
analysis of restriction fragment length polymor-
phisms (RFLPs) using Tsp509I (New England
Biolabs, Ipswich, MA, USA). The Tsp509I enzyme
was selected following analysis of published gene
sequences of representative lineages of hMPV in
GenBank (accession nos AY145294 and AF371337,
AY297749 and AY145301, AY530095, AY145295
and AY525843, and AY304362, for lineages A1,
A2a, A2b, B1 and B2, respectively).
Until 2004, RNA from nasopharyngeal aspi-
rates was extracted using a phenol–chloroform
method (TRIzol LS Reagent; Gibco Life Technol-
ogies, Gaithersburg, MD, USA) according to the
manufacturer’s instructions. From 2004 onwards,
RNA was extracted using an automated Bio-
Robot M48 (Qiagen, Hilden, Germany) and the
MagAttact Virus Mini M48 kit (Qiagen). RNA
was then transcribed to cDNA using reverse
transcriptase M-MuLV enzyme (USB Corp.,
Cleveland, OH, USA) and random primers.
Aliquots of the cDNAs obtained were frozen at
)40C until PCR-RFLP was performed.
In total, 136 cDNA samples (positive for hMPV
according to PCR of the F gene) were thawed and
analysed by PCR-RFLP (11, 11, 12, 31, 36 and 35
samples from 2002, 2003, 2004, 2005, 2006 and 2007,
respectively). These samples were obtained from
>300 children who suffered an episode of acute
respiratory tract infection in which hMPV was
detected during the period 2002–2007. The respon-
sible genotypes had been determined previously
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by sequencing of the amplicon of the F fragment
(348 bp) in an ABI PRISM 3100 Genetic Analyzer
(Applied Biosystems, Foster City, CA, USA), fol-
lowed by comparisonwith sequences at the BLAST
website (http://www.ncbi.nlm.nih.gov/BLAST).
Of the samples investigated, 15 were genotype A1,
74were genotype A2, 35were genotype B1, and 12
were genotype B2.
Genotyping by PCR-RFLP was performed by
digesting 8-lL aliquots of the F fragment ampli-
con with 15 U of Tsp509I for 1 h at 65C to
differentiate between genotypes A and B, and
among lineages A1, A2, B1 and B2. Fragments
were visualised in agarose 3% w ⁄ v gels after
staining with ethidium bromide.
Digestion with Tsp509I resulted in two frag-
ments of 102 and 246 bp for hMPV lineage A1,
two fragments of 76 and 219 bp for hMPV
lineage A2, three fragments of 77, 116 and
153 bp for hMPV lineage B1, and two fragments
of 153 and 193 bp for hMPV lineage B2 (Fig. 1).
There was full agreement between the two
genotyping methods, sequencing and PCR-RFLP
for 133 of the 136 samples. For three samples, the
pattern obtained after PCR-RFLP analysis could
not be allocated to any of the four lineages of
hMPV; according to sequencing, two of these
samples belonged to lineage B1 and the other to
lineage B2. Thus, using Tsp509I, it was possible to
distinguish clearly between the two major geno-
types of hMPV, A and B, and among lineages A1,
A2, B1 and B2, for >95% of the strains.
The epidemiology of the infections caused by
the two genotypes of hMPV varies. There are
several questions concerning the epidemiology
and the clinical significance of the different geno-
types of hMPV that require further investigation.
The prevalence of infections caused by the two
hMPV genotypes varies among geographical
regions. In northern Spain, all four lineages were
circulating in the 2005–2006 season, as was the case
in Japan during 2001–2003 [5]. Mackay et al. [6]
found that all four lineages circulated annually in
Australia, with a single, usually different, hMPV
lineage predominating each year. Within line-
age A2, Huck et al. [7] identified two new clusters,
designated A2a and A2b, and, with few excep-
tions, strains that were genotyped as A2 from
various countries belonged to subgroup A2a. The
present study revealed that Tsp509I PCR-RFLP
could also be used to differentiate between clus-
ters A2a and A2b. Samples of hMPV A2a cDNA
yielded the two fragments described above for
lineage A2, but hMPV A2b samples generated
only one fragment of 295 bp (Fig. 1). Esper et al. [8]
suggested that the CAN98-75 strain (genotype B2)
can cause severe illness. However, in young
children, hMPV genotype A has been reported to
cause more severe disease than hMPV genotype B
[9]. Although not frequent, re-infection with dif-
ferent genotypes can occur [10], suggesting that
infection with one genotype does not protect
against further infections with the other genotype.
To increase our knowledge concerning the
epidemiology of hMPV infections, simple and
accurate methodologies will need to be available
in most laboratories. The availability of a simple,
fast and economical method for genotyping a
large number of hMPV samples at the same time,
e.g., the PCR-RFLP assay described in the present
study, would be useful for epidemiological stud-
ies and, possibly, for predicting severity of illness
in patients infected with hMPV.
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Fig. 1. Typing of human metapneumovirus (hMPV)
according to fusion gene PCR–restriction fragment length
polymorphism (PCR-RFLP) analysis. A partial fusion gene
was amplified by PCR and analysed following digestion
with Tsp509I. Detection of hMPV generated a 348-bp
product. Lanes: 1 and 15, 100-bp DNA molecular size
ladder (Tracklt; Invitrogen, Carlsbad, CA, USA); 2 and 3,
hMPV lineage B1; 4 and 5, hMPV lineage B2; 6–8, hMPV
lineage A1; 9–11, hMPV lineage A2a; 12–14, hMPV line-
age A2b.
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ABSTRACT
This study analysed the time-trends for bacteria
associated with nosocomial lower respiratory
tract infections (LRTIs), bloodstream infections
(BSIs) and urinary tract infections (UTIs) that
were reported to the German Nosocomial Infec-
tion Surveillance System for intensive care units
(ICUs). Data concerning 19 822 nosocomial infec-
tions were submitted by 139 ICUs between 2000
and 2005. There was a significant increase in the
proportion of Gram-negative bacteria causing
LRTIs (from 63.9% to 68.4%) and UTIs (from
65.3% to 68.6%). The proportion of BSIs caused
by Gram-negative bacteria declined significantly,
from 36.4% to 22.7%. The frequency of methicil-
lin-resistant Staphylococcus aureus among all
S. aureus isolates increased from 19.8% to 37.2%.
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Knowledge concerning the distribution of bacteria
as causative agents of infections, together with
their resistance patterns, is essential for selecting
appropriate empirical antibiotic treatment.
Although the microbial aetiologies of nosocomial
infections (NIs) are known to differ among hospi-
tals, or even among departments of the same
hospital [1,2], new developments in healthcare
systems and new treatment strategies might affect
the distribution of bacterial pathogens on a wider
level. Changes in the distribution of bacterial
species, as well as increasing resistance rates over
time, have been reported with respect to NIs in the
USA [3]. The aim of the present study was to
investigate the time-trends in bacteria associated
with NIs in intensive care units (ICUs) in Germany
between 2000 and 2005, and to determine the
prevalence of resistance among selected bacterial
pathogens.
The database of the German Surveillance
System for NIs in ICUs (ICU-KISS) was analysed
to determine the distribution of bacteria associ-
ated with nosocomial lower respiratory tract
infections (LRTIs, i.e., pneumonia and bronchitis),
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